- Country: USA
- Summary: CPRR - Cobas ROCHE REAGENTS/CONSUMABLES - BASE+4, Cinci
- UST Ref No: 118803687
- Deadline: 19 May 2025
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: Refer Document
- Notice Type: Tender
- Document Ref. No.: 36C25025Q0545
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:
- Description
2VAMC Cincinnati, OhioPathology & Laboratory Medicine Service9STATEMENT OF WORK (SOW)FOR THE ACQUISTION OF MOLECULAR INSTRUMENT/ANALYZER I. GENERAL OBJECTIVES AND SCOPECincinnati VAMC Pathology and Laboratory Medicine Service (PALMS) requires an FDA approved fully automated molecular diagnostic system, reagent kits, consumables, supplies, yearly maintenance, and annual customer training for HCV and HIV quantitative viral load testing, CT/NG, TV/MG, HIV 1/2 qualitative, EBV, CMV and HPV testing for clinical diagnostic use. Additional assays may be added to the test menu as they become available at the discretion of the Cincinnati VAMC. The Contractor shall deliver the instrument/analyzer and all related components to the Cincinnati VAMC by September 1, 2025, ensuring installation and setup are completed accordingly.This lease agreement spans one year, with four optional extension years, cost per reportable contract. Acquiring this capability will enables in-house testing, aligning with the VA s 2022-2028 Strategic Plan for timely accessible, and high-quality results. This acquisition enhances efficiency and veteran care. II. BACKGROUNDCincinnati VAMC Pathology and Laboratory Medicine Service (PALMS) is a full-service clinical laboratory, accredited by the Joint Commission, providing high quality testing of blood, fluid, and tissue to support clinicians in diagnosis and treatment of patients.Period of PerformanceCost per test lease agreement for the FDA approved molecular analyzer will be in effect for one (1) base contracting year with options to extend the contract for four (4) additional one (1) year periods.The vendor shall remove all equipment within 90 days after notification of the expiration of the terms of this agreement but not until the completion of new vendor's equipment installation inclusive of completed cross over studies. Vendor shall be responsible for removing the hard drive and turning it over to the Cincinnati VAMC Biomedical Servi... - Documents:
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGINCPRR - Cobas ROCHE REAGENTS/CONSUMABLES - BASE+4, Cinci - USA Tender
The VETERANS AFFAIRS, DEPARTMENT OF, a Government sector organization in USA, has announced a new tender for CPRR - Cobas ROCHE REAGENTS/CONSUMABLES - BASE+4, Cinci. This tender is published on USARFP under UST Ref No: 118803687 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2025-05-19.
The estimated tender value is Refer Document, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
